AME vs LGN: Which Stock Is the Better Buy?
AMETEK, Inc. and Legence Corp. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Industrials.
AI verdict — AME vs LGN, read from the filings
The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.
| AMETEK, Inc. (AME) | Legence Corp. (LGN) | |
|---|---|---|
| Market cap | $55.4B | $14.0B |
| Revenue (latest FY) | $7.40B | $2.55B |
| Net income (latest FY) | $1.48B | $-59.78M |
| Revenue growth (5y CAGR) | 10.3% | 27.0% |
| Net margin | 20.0% | -2.3% |
| Return on equity | 13.9% | -15.2% |
| P/E ratio | 36.5 | — |
| Dividend yield | 0.6% | — |
| Profitable years (of last 10) | 10 | 0 |
| Positive free cash flow | Yes | Yes |
Verify the comparison
Use the filing period and source shown by each tool before treating two figures as comparable.
See the full AME vs LGN breakdown
Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.
Open AME's full financials → Open LGN's full financials →More comparisons
Frequently asked questions
Which is bigger, AME or LGN?
AMETEK, Inc. is larger by market capitalization — $55.4B versus $14.0B.
Which grows faster, AME or LGN?
Over the last five fiscal years, Legence Corp. grew revenue faster — 27.0%/yr versus 10.3%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.
Keep exploring
AME fundamentals → · LGN fundamentals → · All 1,500+ companies → · Free screener →